Literature DB >> 15694152

Cherubism - new hypotheses on pathogenesis and therapeutic consequences.

Peter Hyckel1, Alexander Berndt, Peter Schleier, Joachim H Clement, Volkmar Beensen, Hartmut Peters, Hartwig Kosmehl.   

Abstract

AIMS: The hereditary occurrence of cherubism indicates a probable genetic aetiology: a correlation with a mutation in the gene SH3BP2 has been demonstrated. A convincing concept of formal pathogenesis is not yet available. The study was aimed at advancing the understanding of the pathogenesis of cherubism by presenting a case study including genetic findings and an evaluation of the literature. RESULTS AND
CONCLUSION: Because of its association with the development of the second and third molars, cherubism could be defined as a genetically determined alteration of tooth development. In this context, disturbed PTHrP - PTHrP receptor interaction induced by the mutation in SH3BP2 is discussed. The temporal and spatial determination of the clinical symptoms is explained by an interaction of SH3BP2-dependent signal transduction pathways with jaw morphogenesis (e.g. Hox-gene Msx-1). Because of the disease-induced lack of determination of the cap phase of the second and third molar, a spatial compartmentation, which is necessary for normal dental development, does not take place. This leads to dysregulation of mesenchymal bone building tissue areas, and to the development of giant cell granulomas with high osteoclastic activity. Because of the genetic determination of cherubism and the associated dedifferentiation of the diseased tissue, a surgical removal should be exclusively restricted to specific indications. Therefore an attitude of wait and see is preferred.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694152     DOI: 10.1016/j.jcms.2004.07.006

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  25 in total

1.  Cherubism: case report with review of literature.

Authors:  Divya Mehrotra; Abhishek Kesarwani
Journal:  J Maxillofac Oral Surg       Date:  2011-03-22

2.  Clinico-pathologic conference AAOMP/IAOP 2008: case 3.

Authors:  M Vered; I O Bello; T Salo; I Allon
Journal:  Head Neck Pathol       Date:  2008-09-13

3.  [Central giant cell granuloma of the mandible. Definition and differential diagnosis].

Authors:  O Driemel; R Staudenmaier; K Hertel; H Pistner; H Kosmehl
Journal:  HNO       Date:  2006-09       Impact factor: 1.284

4.  Identical Mutation in SH3BP2 Gene Causes Clinical Phenotypes with Different Severity in Mother and Daughter - Case Report.

Authors:  L Preda; O Dinca; A Bucur; C Dragomir; E Severin
Journal:  Mol Syndromol       Date:  2010-06-09

5.  Cherubism: a case report.

Authors:  Saikrishna Degala; K P Mahesh
Journal:  J Maxillofac Oral Surg       Date:  2013-02-24

6.  Cherubism misdiagnosed as giant cell tumor: a case report and review of literature.

Authors:  Yang Jiao; Mi Zhou; Yaowu Yang; Jun Zhou; Xiaohong Duan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

7.  Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.

Authors:  Alessandra Pires Duarte; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez; Fabrício Rezende Amaral
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

8.  So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.

Authors:  Konstantinos I Tosios; Rajaram Gopalakrishnan; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2008-08-23

9.  Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.

Authors:  Prokopios P Argyris; Rajaram Gopalakrishnan; Ying Hu; Ernst J Reichenberger; Ioannis G Koutlas
Journal:  Head Neck Pathol       Date:  2017-07-18

Review 10.  Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.

Authors:  J E O'Connell; G J Kearns
Journal:  Ir J Med Sci       Date:  2012-10-26       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.